Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bogdan Lesyng

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Chemotherapy and Pharmacology|February 23, 2011
A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancerAhmed Ashour Ahmed, Juliet Goldsmith, Izabela Fokt, et al.
Frontiers in Cell and Developmental Biology|June 30, 2025
Hypoxia alters the response of ovarian cancer cells to the mitomycin C drugAleksandra Gawrylak, Klaudia Brodaczewska, Roksana Iwanicka-Nowicka, et al.
Journal of Inorganic Biochemistry|March 3, 2018
Synthesis, structural and antimicrobial studies of type II topoisomerase-targeted copper(II) complexes of 1,3-disubstituted thiourea ligandsAnna Bielenica, Aleksandra Drzewiecka-Antonik, Paweł Rejmak, et al.
Biochemistry|February 11, 2012
Activities of topoisomerase I in its complex with SRSF1Takao Ishikawa, Krystiana A Krzysko, Barbara Kowalska-Loth, et al.
Cancer Biology & Therapy|May 5, 2012
Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cellsKarolina Swiatek-Machado, Jakub Mieczkowski, Aleksandra Ellert-Miklaszewska, et al.
Cancer Chemotherapy and Pharmacology|March 24, 2006
Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells"Theodore J Lampidis, Metin Kurtoglu, Johnathan C Maher, et al.
Biochimica Et Biophysica Acta|March 26, 2013
Development of novel molecular probes of the Rio1 atypical protein kinaseMarcin Mielecki, Krzysztof Krawiec, Irene Kiburu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Chemotherapy and Pharmacology|February 23, 2011
A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancerAhmed Ashour Ahmed, Juliet Goldsmith, Izabela Fokt, et al.
Frontiers in Cell and Developmental Biology|June 30, 2025
Hypoxia alters the response of ovarian cancer cells to the mitomycin C drugAleksandra Gawrylak, Klaudia Brodaczewska, Roksana Iwanicka-Nowicka, et al.
Journal of Inorganic Biochemistry|March 3, 2018
Synthesis, structural and antimicrobial studies of type II topoisomerase-targeted copper(II) complexes of 1,3-disubstituted thiourea ligandsAnna Bielenica, Aleksandra Drzewiecka-Antonik, Paweł Rejmak, et al.
Biochemistry|February 11, 2012
Activities of topoisomerase I in its complex with SRSF1Takao Ishikawa, Krystiana A Krzysko, Barbara Kowalska-Loth, et al.
Cancer Biology & Therapy|May 5, 2012
Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cellsKarolina Swiatek-Machado, Jakub Mieczkowski, Aleksandra Ellert-Miklaszewska, et al.
Cancer Chemotherapy and Pharmacology|March 24, 2006
Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells"Theodore J Lampidis, Metin Kurtoglu, Johnathan C Maher, et al.
Biochimica Et Biophysica Acta|March 26, 2013
Development of novel molecular probes of the Rio1 atypical protein kinaseMarcin Mielecki, Krzysztof Krawiec, Irene Kiburu, et al.
Pageof 3